Physician profile
Alyssa E Zipadelli
NPI 1760197412
$2,045.86
in general payments reported to CMS, 2019-2025
21 companies · $632 in 2025
The $632 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $253 · 2024: $1,161 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,045.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $250.13 | 2025 | Tremfya |
| Spr Therapeutics, INC | $196.32 | 2024-2025 | Sprint Pns System |
| Vertos Medical, INC. | $192.96 | 2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $187.21 | 2023-2024 | Belbuca, Xtampza |
| Valinor Pharma, LLC | $178.35 | 2023-2024 | Movantik |
| Pfizer INC. | $175.33 | 2024 | |
| Saluda Medical Americas, INC. | $138.74 | 2024 | Evoke |
| Genzyme Corporation | $110.16 | 2025 | |
| Novartis Pharmaceuticals Corporation | $108.85 | 2023 | |
| Lundbeck LLC | $99.95 | 2024 | Vyepti |
| Takeda Pharmaceuticals U.S.A., INC. | $68.89 | 2025 | Entyvio |
| Abbvie INC. | $58.40 | 2023-2024 | |
| Painteq LLC | $56.36 | 2023-2024 | Painteq |
| Lilly USA, LLC | $49.25 | 2025 | Omvoh |
| Si-Bone, INC. | $44.39 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $28.46 | 2024 | |
| Scilex Pharmaceuticals INC. | $23.22 | 2024 | |
| Azurity Pharmaceuticals, INC. | $22.66 | 2024 | Horizant |
| Medtronic, INC. | $22.60 | 2024 | Intellis Adaptivestim |
| Alnylam Pharmaceuticals INC. | $18.53 | 2023 | Onpattro |
| Janssen Pharmaceuticals, INC | $15.10 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Zipadelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.